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Abstract
Oral tolerance can be induced in some mouse strains by gavage or spontaneous ingestion of dietary antigens. In the present 
study, we determined the influence of aging and oral tolerance on the secretion of co-stimulatory molecules by dendritic cells 
(DC), and on the ability of DC to induce proliferation and cytokine secretion by naive T cells from BALB/c and OVA transgenic 
(DO11.10) mice. We observed that oral tolerance could be induced in BALB/c mice (N = 5 in each group) of all ages (8, 20, 
40, 60, and 80 weeks old), although a decline in specific antibody levels was observed in the sera of both tolerized and im-
munized mice with advancing age (40 to 80 weeks old). DC obtained from young, adult and middle-aged (8, 20, and 40 weeks 
old) tolerized mice were less efficient (65, 17 and 20%, respectively) than DC from immunized mice (P < 0.05) in inducing 
antigen-specific proliferation of naive T cells from both BALB/c and DO11.10 young mice, or in stimulating IFN-γ, IL-4 and IL-10 
production. However, TGF-β levels were significantly elevated in co-cultures carried out with DC from tolerant mice (P < 0.05). 
DC from both immunized and tolerized old and very old (60 and 80 weeks old) mice were equally ineffective in inducing T cell 
proliferation and cytokine production (P < 0.05). A marked reduction in CD86+ marker expression was observed in DC isolated 
from both old and tolerized mice (75 and 50%, respectively). The results indicate that the aging process does not interfere with 
the establishment of oral tolerance in BALB/c mice, but reduces DC functions, probably due to the decline of the expression 
of the CD86 surface marker.
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Dendritic cells (DC) are the main antigen-presenting 
cells involved in the initiation of the immune response 
against exogenous antigens by stimulating naive T cells 
(1), but they have also been associated with the deletion 
or silencing of auto-reactive lymphocytes that leads to 
central and/or peripheral tolerance (2-4). In the context 
of tolerance, DC play an important role in the responses 
to exogenous antigens, mainly to dietary proteins, and in 
the inhibition of auto-reactive T cells that have escaped 
negative selection in the thymus (2,3).
Dendritic cells are able to produce IL-12 in response 
to inflammatory stimuli, thus leading to T helper (Th) cell 
differentiation to Th1. However, in microenvironments 
containing IL-10, the production of IL-12 is inhibited 
(5,6). It has been shown that DC generated from human 
peripheral blood can assume a tolerogenic function after 
treatment with IL-10, inhibiting allogenic mixed leukocyte 
reactions and the anti-CD3-induced response of primed 
and naive CD4+ T cells (6). 
The blockage of the co-stimulatory molecule, CD86, or 
its binding to CTLA-4 receptors on lymphocytes, rather than 
its interaction with CD28, seems to induce oral tolerance 
by inhibiting the secretion of transforming-growth factor 
beta (TGF-β) (7). However, other studies have shown 
that DC obtained from the gastrointestinal tract of mice 
do not present variations in the expression of the CD80 
and CD86 molecules in oral tolerance or in priming with 
the antigen (8). 
Senescence of the immune system leads to a decline 
in the responses to exogenous antigens as well as in the 
susceptibility to tolerance (9-11). The alterations observed 
in immunosenescence are attributed, at least in part, to 
the changes in maturation of T and B lymphocytes (11,12). 
However, these alterations might reflect changes in the 
capacity of processing and/or presenting antigens by 
the DC.
The effects of aging on DC phenotype and function have 
been investigated, but the results are still controversial. 
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There are reports indicating that DC derived from the pe-
ripheral blood of humans do not show significant phenotype 
or functional alterations with aging (13). On the other hand, 
DC differentiated in vitro from precursors obtained from the 
bone marrow of old mice show an increased secretion of 
IL-10 and a reduced secretion of tumor necrosis factor alpha 
(TNF-α) and IL-6 after stimulation with lipopolysaccharide 
compared to the DC obtained from young mice (14). 
Besides aging, genetic background can also influence the 
susceptibility to induction or maintenance of oral tolerance 
(11,15-19). Several murine models have been developed to 
study the phenomenon of central tolerance, and deletion of 
autoreactive clones of lymphocytes is the main mechanism 
involved (20-22). About 70-75% of all thymocytes from the 
DO11.10 mouse bear the transgenic T-cell receptor (TCR)-
α-β and chains that recognize the ovalbumin (OVA) peptide 
323-339 presented by the major histocompatibility complex 
(MHC) I-Ad. The administration of the antigen peptide by 
the intraperitoneal route led to a rapid deletion of immature 
thymocytes, CD4+CD8+ TCRlow cells, which were reduced to 
15 to 20% (20). The intake of OVA plus anti-IL-12 enhances 
apoptosis in peripheral lymphoid organs of DO11.10 (23). 
However, data from our laboratory have shown that the 
DO11.10 mice did not become tolerant upon continuous 
feeding with OVA (24). We also showed that, unlike the DC 
from BALB/c mice, DC from young transgenic mice that 
had ingested OVA were as efficient as naive DC or DC from 
immunized mice in inducing proliferation and secretion of 
cytokines by naive T cells (24).
In the present study, we investigated the effects of aging 
and oral tolerance on the expression of CD80 and CD86 
surface markers by DC and on the ability of these cells to 
stimulate the proliferation of naive T cells obtained from 
BALB/c and OVA transgenic (DO11.10) mice, and to induce 
cytokine production in co-cultures of DC and T cells.
Material and Methods
Mice
TCR OVA-specific transgenic mice (clone DO11.10) (20) 
and BALB/c mice were supplied by the Multi-Institutional 
Center for Biological Investigation of the State Univer-
sity of Campinas. Mice were housed under pathogen-free 
conditions and fed a diet of autoclaved food and water. 
BALB/c mice were classified into five age groups (N = 5 
in each group): young (8 weeks of age), adults (20 weeks 
of age), middle-aged (40 weeks of age), old (60 weeks of 
age), and very old (80 weeks of age) mice based on the 
results of previous research on age-related antibody and 
cytokine decrease (10). The study was approved by the 
Institutional Ethics Committee for Animal Experimentation 
(Protocol #594-1).
Reagents
Type V bovine serum albumin (BSA), 35% BSA solution, 
and type VI OVA (Conalbumin) were purchased from Sigma 
Chemical Co. (USA). Ovalbumin for oral tolerization was 
purchased from Rhoster Indústria e Comércio Ltda. (Brazil). 
Rabbit anti-mouse antibody was prepared and conjugated 
to type IV horseradish peroxidase (HRPO, Sigma) in our 
laboratory. The following antibodies were purchased: clone 
HL-3 (anti-mouse CD11c-phycoerythrin (PE) conjugate; 
BD Pharmingen, USA), clone TIB229 (anti-class II MHC-
fluorescein isothiocyanate (FITC) conjugate; prepared in our 
laboratory), clone 16-10A1 (anti-CD80-FITC; BD Pharmin-
gen), clone GL1 (anti-CD86-FITC; BD Pharmingen), clone 
145-2C11 (anti-CD3-PE; BD Pharmingen), clone L3T4 
(anti-CD4-FITC; BD Pharmingen), and isotype controls for 
cytometry assays (BD Pharmingen). 
Induction of tolerance and immunization 
BALB/c mice of each age group were immunized or 
tolerized as described elsewhere (24). Briefly, mice were 
immunized by the intraperitoneal (ip) route with 10 mg OVA 
+ 1 mg aluminum hydroxide in saline, and 14 days later they 
were boosted with 10 mg OVA. For tolerance induction, mice 
received OVA (4 mg/mL) in drinking water for 7 consecutive 
days. One week later, the mice were challenged ip with 10 
mg OVA + 1 mg aluminum hydroxide and, after 2 weeks, 
they were given a booster of 10 mg OVA in saline. Seven 
days after the last procedure, immunized, tolerized and 
control (naive) mice were bled and the sera were separated 
for antibody detection. Mice were then killed to isolate DC, 
as described below.
Antibody assays
Antibody titers to OVA were determined by a standard 
enzyme-linked immunosorbent assay (ELISA) using an 
automatic ELISA reader (Multiskan II, MS, Labsystem, 
Finland) as described elsewhere (24). Microtiter plates 
(Falcon, Becton-Dickinson, USA) were coated with OVA by 
adding 50 μL of the protein solution (20 μg/mL in carbon-
ate/bicarbonate buffer, pH 9.6) to each well and incubating 
the plates for 1 h at 37°C and then overnight at 4°C. The 
wells were washed with phosphate-buffered saline (PBS) 
containing 0.05% Tween 20 (PBS-T) and then blocked with 
5% (w/v) skimmed milk in PBS (PBS-SM) for 1 h at 37°C. 
After washing, the plates were incubated for 1 h at 37°C 
with mouse serum samples diluted from 1:100 to 1:12,800 
in PBS. After further washing with PBS-T, the plates were 
incubated with a rabbit anti-mouse immunoglobulin-HRPO 
conjugate (275 ng/mL). Sixty minutes later, all reagents 
were removed by washing and 50 μL freshly prepared 
substrate (0.04% ortho-phenylenediamine and 0.03% 
H2O2 in 50 mM citric acid/di-sodium hydrogen phosphate 
buffer, pH 5.5) was added to each well. After 30 min in the 
dark, 25 µL 4 N H2SO4 was added to the wells to stop the 
reaction and the absorbances were read at 492 nm. The 
results are reported as scores obtained by means ± SEM 
of the absorbance values of serum dilutions from 1:100 to 
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1:12,800 of each mouse.
DC enrichment
Spleen DC-enriched populations were obtained as pre-
viously described (24) from BALB/c mice of 8, 20, 40, 60, 
and 80 weeks of age. Briefly, spleen cells of BALB/c mice 
were resuspended in a 35% BSA solution (density of 1.08 
g/mL) and centrifuged at 4000 g for 40 min at 4°C. Cells 
collected from the interface were transferred to a plastic 
dish and incubated for 90 min. Non-adherent cells were 
removed by washing, and the monolayer was incubated 
for an additional 18 h in the presence of OVA (Conalbumin, 
500 µg/mL). The DC detached spontaneously after this 
period of culture, and this enrichment was followed by flow 
cytometry (FACScalibur, Becton-Dickinson) using DC mark-
ers anti-CD11cαchain APC (clone HL-3; BD Pharmingen), 
anti-class II MHC PE (clone M5/114.15.2; Miltenyi Biotec, 
Germany), anti-CD80 FITC (14-10A1; BD Pharmingen), 
and anti-CD86 FITC (GL1; BD Pharmingen). Amplification 
and compensation were determined by the examination of 
unlabeled cells, and analyses were carried out using the 
Cell Quest software (Becton-Dickinson). Data are reported 
as percent positive cells and geometric mean fluorescence 
intensity. Enriched DC preparations contained approxi-
mately 80% class II MHC+, 60% CD11c+, 30% 33D1+, and 
13% CD205+ cells.
T cell enrichment
The T cell populations were enriched from spleens 
of 8-week-old naive BALB/c or DO11.10 transgenic mice 
using the protocol of adhesion to nylon wool, as described 
previously (24). T cell enrichment was monitored by flow 
cytometry, and the cell suspensions obtained contained 
approximately 75% CD3+ and 50% CD4+ cells. T CD4+ 
cells from naive DO11.10 mice were 80-90% KJ1.26 
positive.
T cell antigen-specific proliferation 
T cell proliferation assays were carried out as described 
elsewhere (24). Briefly, T cells (1 x 106 cells/well) and 
DC (5 x 104 cells/well) were co-cultured in flat-bottomed 
96-well plates in the presence of the antigen (500 µg/
mL OVA) for 96 h, and supernatants (half volume) were 
collected for cytokine determination. -[4,5-Dimethyltiazol-
2-yl] diphenyltetrazolium bromide solution (MTT, Sigma) 
was added to the cultures (5 mg/mL; 10 µL/well) and the 
plates were incubated for an additional 4 h. After dissolving 
formazan crystals, absorbance at 540 nm was measured 
with an ELISA reader.
Cytokine measurement
Cytokines were determined in the supernatants of the 
co-cultures of T cells and DC using commercial ELISA 
tests for IL-1, IL-2, IL-4, IL-10, interferon gamma (IFN-γ), 
and TGF-β (BD Pharmingen) according to manufacturer 
instructions. Absorbance was read at 450 nm, with the 
wavelength of 540 nm used for correction. 
Statistical analysis
One-way ANOVA followed by the Bonferroni test was 
applied to compare the different experimental groups, with 
the level of significance set at P < 0.05. 
Results 
Influence of age on the humoral immune response of mice
The humoral immune response of BALB/c mice (8, 20, 
40, 60, and 80 weeks of age) was investigated as a function 
of oral treatment with OVA followed by an ip challenge or ip 
immunization, and the levels of specific serum antibodies 
were determined by ELISA. Figure 1 summarizes the results 
obtained in these experiments. The mice treated only with 
an ip injection of OVA produced specific antibodies at sig-
nificantly higher levels than non-immunized control animals, 
although a marked age-dependent reduction in these levels 
was observed. The mice of all ages evaluated became toler-
ant to OVA after voluntary ingestion of the protein, presenting 
significantly lower levels of anti-OVA antibodies compared 
to ip-treated mice (P < 0.05). No significant differences in 
serum antibody levels produced by tolerant animals of the 
different age groups were observed.
Figure 1. Effect of age and route of ovalbumin (OVA) adminis-
tration on antibody production by BALB/c mice. Immunoglobulin 
G-specific antibodies were detected in sera of 8-, 20-, 40-, 60- 
and 80-week-old BALB/c mice (N = 5 in each group) after 7 con-
secutive days of ingestion (dark gray bars) or non-ingestion (light 
gray bars) of a 4-mg/mL OVA solution. All mice were challenged 
twice intraperitoneally with OVA and sera were collected 7 days 
later. Antibodies were measured by ELISA, with each column in-
dicating means ± SEM of individual running sums of absorbance 
readings of serum dilutions from 1:100 to 1:12,800. Horizontal 
dashed line indicates the absorbance reading in control serum. 
Data are representative of three separate experiments (*P < 0.05 
compared to non-ingestion of OVA; one-way ANOVA followed by 
the Bonferroni test).
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Influence of age and immunological status on DC 
activity 
Enriched DC preparations from the spleen of BALB/c 
mice (8, 20, 40, 60, and 80 weeks of age), both tolerant and 
immune to OVA, were evaluated regarding the expression 
of CD80 and CD86 using flow cytometry. No alteration was 
observed in the percent of cells expressing CD80 in DC 
from the different experimental groups studied (data not 
shown). As depicted in Figure 2, the percents of CD86+ 
cells were more reduced in DC isolated from the tolerant 
mice, and also decreased as a function of aging. Similarly, 
the expression of the CD86 marker suffered a reduction 
related to age and to type of immunization (Figure 2). 
The DC from BALB/c mice of different ages immunized 
with OVA either orally or ip were used in tests involving 
antigen presentation to naive T lymphocytes obtained from 
young BALB/c and DO11.10 mice; DC from naive mice were 
used as controls. The T/DC co-cultures were conducted in 
the presence of 500 µg/mL OVA for 4 days. The prolifera-
tion of T lymphocytes and the production of Th1 and Th2 
cytokines were then evaluated. The results of these tests 
are summarized in Figure 3. T lymphocytes obtained from 
BALB/c mice (panel A) and DO11.10 mice (panel B) showed 
significantly higher proliferation rates when cultivated with 
DC obtained from mice up to 40 weeks of age treated ip 
with OVA, than cells cultured in the presence of DC from 
Figure 2. Age-related changes in CD86 surface marker expression in dendritic cells (DC) from immunized and tolerant BALB/c mice. 
An enriched preparation of spleen DC from BALB/c mice of 8, 20, 60, and 80 weeks of age (N = 5 in each group) after ingestion of a 
4-mg/mL ovalbumin (OVA) solution for 7 consecutive days (tolerized) or not (immunized), followed by an intraperitoneal challenge was 
used for the study. Enriched DC suspensions were cultured with OVA for 18 h, labeled with an anti-CD86-FITC antibody and analyzed 
by flow cytometry. Data represent the percentage of CD86-positive cells (%) and the geometric mean fluorescence intensity (MFI) of 
all pooled cells harvested after overnight culture over background staining with an isotype-matched control (gray line). Results are 
representative of two separate experiments pooled from 5 mice.
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non-immunized mice. T cell proliferation was significantly 
reduced in cultures carried out with DC collected from mice 
up to 40 weeks of age that ingested OVA compared to DC 
from animals immunized ip. DC from non-immune mice of 
all the age ranges examined were equally capable of stimu-
lating the proliferation of naive T lymphocytes cultivated in 
the presence of OVA.
The levels of IFN-γ and IL-4 were increased in co-
cultures carried out with DC from either immunized or toler-
ized mice up to 20 weeks of age. However, the levels 
of these cytokines were significantly lower (P < 0.05) 
when DC were obtained from BALB/c mice tolerant 
to OVA (Figure 4) compared to DC from ip-immunized 
mice, at least when DC were obtained from mice up 
to 40 weeks of age. At the time of their removal, the 
supernatants showed no significant differences in IL-2 
levels either in relation to the type of immunization or 
to the age of the DC donors (data not shown).
The levels of IL-10 in the supernatants of co-
cultures using DC from immunized mice showed an 
age-dependent increase up to the age of 40 weeks. 
The co-cultures with DC from BALB/c mice tolerant 
to OVA showed significantly lower IL-10 levels than 
did those with the cells of immune BALB/c mice, 
independently of the age range analyzed (Figure 5, 
panels A and B). 
On the other hand, TGF-β secretion increased 
in the supernatants of T cells from both BALB/c and 
DO11.10 animals cultured in the presence of tolerant 
DC from young BALB/c mice (up to 8 weeks of age), 
but not when the co-cultures included DC collected 
from older mice or from those immunized ip with OVA 
(Figure 5, panels C and D).
The secretion of IL-1 did not suffer significant 
changes in co-cultures with DC from tolerant or im-
munized mice. However, an age-dependent increase 
in the level of this cytokine was found when DC 
were obtained from mice up to the age of 60 weeks 
(Figure 6).
Discussion 
Various literature reports have shown alterations 
in the immune response as a function of age (25,26), 
but few have been concerned with the effects of ag-
ing on the DC in the context of tolerance or immunity 
(for a review, see Ref. 27). In the present study, we 
evaluated the immune responses of BALB/c mice 
ranging in age from young (8 weeks old) to very old 
(80 weeks old).
We found that middle-aged mice (40 weeks old) 
already revealed a diminished humoral immune re-
sponse, as shown by the levels of anti-OVA antibodies, 
which were significantly lower than in younger animals 
after parenteral administration of the antigen. These 
results suggest that the establishment of immunity is easier 
in younger animals, supporting previous literature data 
(10,24,28,29). Tolerance was well preserved in all groups of 
mice studied. However, the differences in the antibody levels 
of immunized and tolerized mice decreased with advancing 
age. Literature data show that the capacity of becoming 
tolerant to an orally administered antigen is better preserved 
in younger animals, but that some degree of tolerance can 
be induced in very old animals (11,15,16,19). 
Figure 3. Influence of age and regimen of antigen administration on 
dendritic cell (DC)-induced T cell proliferation. Data are reported as 
means ± SEM absorbance observed in cultures of T cells enriched from 
a pool of spleens of 5 BALB/c (Panel A) and 5 DO11.10 (Panel B) mice 
in the presence of DC from 8-, 20-, 40-, 60- and 80-week-old BALB/c 
mice (N = 5 in each group) that had ingested (dark gray bars) or not 
(light gray bars) an ovalbumin (OVA) solution (4 mg/mL) and that were 
challenged intraperitoneally with OVA. The open columns indicate T-cell 
proliferation in the presence of DC from naive mice and the horizontal 
dashed line indicates T cells cultured in the absence of DC. Co-cultures 
were stimulated with 500 μg/mL OVA. Proliferation was measured by 
-[4,5-dimethyltiazol-2-yl] diphenyltetrazolium bromide (MTT) staining 
assays carried out in triplicate. Data are representative of three sepa-
rate experiments (*P < 0.05 indicated by the horizontal lines on top of 
the columns; one-way ANOVA followed by the Bonferroni test).
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DC are fundamental for the development of immunity 
or tolerance to protein antigens. The expression of class II 
MHC molecules, co-stimulatory molecules CD80 and CD86, 
as well as the production of cytokines such as IL-12 by DC, 
play an important role in the response to inflammatory agents 
present in the environment, such as microbial antigens. On 
Figure 4. Production of IFN-γ and IL-4 
by dendritic cell (DC)/T cell co-cultures: 
influence of age and form of antigen ad-
ministration on DC donors. Detection of 
IFN-γ (Panels A and B) and IL-4 (Panels 
C and D) in supernatants of T cells en-
riched from a pool of spleens of 5 BALB/c 
(Panels A and C) and 5 DO11.10 (Pan-
els B and D) mice co-cultured with DC 
from BALB/c mice of 8, 20, 40, 60, and 
80 weeks of age (N = 5 in each group) 
that ingested (dark gray bars) or did not 
ingest (light gray bars) an ovalbumin 
(OVA) solution (4 mg/mL) and that were 
challenged intraperitoneally with OVA. 
Cultures were stimulated with 500 μg/
mL OVA for 96 h, and cytokine levels 
in the supernatants were determined 
by ELISA. Data are representative of 
three separate experiments, each car-
ried out in triplicate. Horizontal dashed 
lines indicate cytokine production by T 
cells cultured in the absence of DC (*P 
< 0.05 compared to non-ingestion of 
OVA; one-way ANOVA followed by the 
Bonferroni test).
Figure 5. IL-10 and TGF-β production 
by dendritic cell (DC)/T cell co-cul-
tures: influence of age and regimen of 
antigen administration on DC donors. 
Detection of IL-10 (Panels A and B) 
and TGF-β (Panels C and D) in super-
natants of T cells enriched from a pool 
of 5 spleens of BALB/c (Panels A and 
C) and 5 DO11.10 (Panels B and D) 
mice co-cultured with DC from BALB/c 
mice of 8, 20, 40, 60, and 80 weeks 
of age (N = 5 in each group) that in-
gested (dark gray bars) or did not 
ingest (light gray bars) an ovalbumin 
(OVA) solution (4 mg/mL) and were 
intraperitoneally challenged with OVA. 
Cultures were stimulated with 500 μg/
mL OVA for 96 h, and cytokine levels 
in the supernatants were determined 
by ELISA. Data are representative of 
three separate experiments, each car-
ried out in triplicate. Horizontal dashed 
lines indicate cytokine production by T 
cells cultured in the absence of DC (*P 
< 0.05 compared to non-ingestion of 
OVA; one-way ANOVA followed by the 
Bonferroni test).
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the other hand, the participation of DC in the induction of 
peripheral tolerance seems to depend on the existence of 
certain tolerogenic factors in the environment in which the 
immune responses are being processed, such as IL-10 
and TGF-β (for reviews, see Refs. 3,30). Numerous data in 
the literature show the involvement of immature DC in the 
establishment of tolerance in the presence of exogenous 
antigens, especially dietary proteins (3,30). However, there 
is evidence that mature DC can also induce peripheral 
tolerance in specific T cells that have escaped negative 
selection (2). In the present study, we have investigated the 
capacity of mature spleen DC from orally or ip-treated mice 
to maintain the antigen-specific proliferation of naive T cells, 
as well as the production of cytokines in T/DC co-cultures. 
We observed that DC collected from mice tolerant to OVA 
were able to present antigens to naive T lymphocytes, 
although in somewhat reduced levels compared to those 
of animals immunized ip. 
The literature shows that the numbers and functions of 
DC are altered during aging (for a review, see Ref. 27). In 
this regard, it has been shown that the number of DC and 
follicular DC found in Peyer’s patches are more reduced 
in older individuals than in younger ones (27,31,32). In 
addition, the proliferative response and production of 
cytokines by TCD4+ spleen lymphocytes from tolerant 
young mice are lower than those of older mice (31). Cor-
roborating literature data, the results obtained here show 
that DC from immunized and tolerized young mice (8-40 
weeks old) differed significantly in their capacity to activate 
T lymphocytes. However, DC from either immunized or 
tolerized older mice present an equally reduced capacity 
to sustain T cell proliferation.
We observed in the present study that the production of 
IFN-γ, IL-4 and IL-10 by naive T lymphocytes was affected 
by both the immune status and age of DC donors. The levels 
of these cytokines were higher in the co-cultures carried 
out with DC from young to middle aged immunized mice 
than in those with DC from tolerant mice, indicating that 
oral administration of OVA can induce a tolerogenic phe-
notype in DC. In agreement, TGF-β levels were increased 
in co-cultures carried out with DC from tolerized younger 
(8 weeks old) mice. It is well known that oral administration 
of the antigen leads to active suppression of the immune 
response by various types of regulatory cells such as Th3, 
regulatory T type 1 (CD4+CD25+) and CD4+CD45Rblow 
cells, which secrete TGF-β (3,32-35), as well as TCD4+ 
latency-associated peptide (LAP)+ cells that express TGF-β 
in a latent form on the membrane of the cells (36). Indeed, 
we observed that DC from tolerized young mice can en-
able naive T cells to produce TGF-β, probably by in vitro 
expansion of naturally occurring regulatory T cells. Literature 
data suggested that IL-1 production by DC is important to 
initiate the cascade of inflammatory cytokines that influence 
the generation of Th1 cells (37). Interestingly, we observed 
that IL-1 was produced at low levels in co-cultures of DC 
from young mice, and did not suffer significant changes 
as a result of tolerance or immunization. In addition, we 
observed an age-dependent increase in IL-1 levels in the 
absence of changes in TGF-β levels in experimental groups 
aged 20 to 60 weeks. Taken together, these results suggest 
that naive T cells produce the secreted form of TGF-β only 
in the presence of low levels of IL-1, and this may account 
for the establishment of oral tolerance in the early stages 
Figure 6. IL-1 production by dendritic cell (DC)/T cell co-cultures: 
influence of age and regimen of antigen administration on DC 
donors. Detection of IL-1 in supernatants of T cells enriched from 
a pool of 5 spleens of BALB/c (Panel A) and 5 DO11.10 (Panel 
B) mice co-cultured with DC from BALB/c mice of 8, 20, 40, 60, 
and 80 weeks of age (N = 5 in each group) that ingested (dark 
gray bars) or did not ingest (light gray bars) an ovalbumin (OVA) 
solution (4 mg/mL) and were intraperitoneally challenged with 
OVA. Cultures were stimulated with 500 μg/mL OVA for 96 h, and 
cytokine levels in the supernatants were determined by ELISA. 
Data are representative of three separate experiments, each car-
ried out in triplicate. Horizontal dashed lines indicate cytokine 
production by T cells cultured in the absence of DC (*P < 0.05 
compared to non-ingestion of OVA; one-way ANOVA followed by 
the Bonferroni test).
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